Evaluating Warfarin Management by Pharmacists in a Community Teaching Hospital
Design: Retrospective cohort study.
Setting: Community teaching hospital.
Patients, Participants: Patients were randomly selected from the Inpatient AMS from January 1, 2009 to January 1, 2011. Patients were included if they were 18 of age years or older and received warfarin for at least three days and excluded for indefinite warfarin discontinuation or an indication following orthopedic surgery. A total of 179 patients were included in each group.
Interventions: The electronic medical record was reviewed for demographics, warfarin indication and goal range, international normalized ratios (INRs), albumin, drug-drug interactions, bleeding, and thrombotic rates.
Main Outcome Measures: Primary endpoints included mean time to therapeutic INR, mean time within goal, frequency of supratherapeutic INRs, bleeding, thrombotic rates, and mean INR on discharge.
Results: There was no statistically significant difference in the time required to reach a therapeutic INR; 3.17 vs. 2.65 days (95% confidence interval -0.09-1.13; P = 0.093). However, the pharmacist group resulted in a lower frequency of supratherapeutic INRs and significantly more time within goal range.
Conclusion: Similar results were observed for pharmacistmanaged and physician-managed patients for INR monitoring and outcome rates. However, the pharmacistmanaged patients demonstrated a lower incidence of supratherapeutic INRs and significantly more time within goal.
Keywords: AE = Adverse events; AMS = Anticoagulation management service; Afib = Atrial fibrillation; Anticoagulation; CT = Computed tomography; DVT = Deep venous thrombosis; FDA = Food and Drug Administration; FFP = Fresh frozen plasma; Hgb = Hemoglobin; INR = International normalized ratio; International normalized ratio; Joint Commission; NNT = Number needed to treat; NPSG = National Patient Safety Goal; PE = Pulmonary embolism; PI = Performance improvement; PMS = Pharmacokinetics Monitoring Service; Pharmacist; Pharmacokinetics; Scr = Serum creatinine; TTR = Time in therapeutic range; Warfarin
Document Type: Research Article
Publication date: 01 February 2014
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites